The digital health market moves fast, speaks its own language, and punishes investors who rely on generic due diligence. Knowing whether a startup's commercialisation strategy is credible — or whether a portfolio company is on track to deliver — requires deep operational experience on the inside.

That's what I bring to the table.

Most digital health startups present compelling narratives. Pitch decks are polished, TAMs are large, and every founding team has conviction. But the difference between a startup that commercialises successfully and one that burns through its runway chasing the wrong model often only becomes visible once you're already invested.

And when things go wrong inside a portfolio company, investors need more than advice — they need someone who can step in, steady the ship, and make the hard calls.

I work with healthcare investors at both moments: before you commit capital, and after — when it matters most.

What I help you with:

The deck looks good. But is the commercial strategy actually credible?

I provide independent expert assessment of digital health startups — not from a generalist perspective, but from someone who has built and commercialised digital health products, inside pharma and alongside startups. I'll tell you what a realistic path to revenue looks like, where the strategic gaps are, and whether the team has what it takes to close them.

• Validating the startup's business model and commercial logic

• Assessing the go-to-market strategy and launch readiness

• Evaluating leadership team capability and organisational set-up

• Scrutinising user adoption strategy and market access approach

➽ Post-investment: keeping your portfolio on track

You've invested. Now how do you make sure the startup actually delivers?

The gap between a strong founding team and a commercially scaled business is where most digital health startups struggle. I work directly with your portfolio companies as a strategic advisor, board member, or interim leader — helping them sharpen their strategy, navigate pharma partnerships, and build the commercial muscle they need to grow.

• Strategic advisory and board membership

• Interim or fractional leadership

• Commercial strategy refinement and execution support

• Pharma partnership development and navigation

Evaluating a digital health investment — or concerned about a portfolio company?

Let's spend 30 minutes on it. I'll give you an honest, experienced perspective on what you're looking at and what the real risks are.

Book a free intro call

A portfolio company is off-course. You need someone who can step in fast and make clear-eyed decisions.

Sometimes a portfolio company needs more than strategic guidance — it needs decisive leadership during a transition. I've done this before. I can move quickly, communicate clearly across stakeholders, and make the structural decisions that protect both the company and your investment.

• Interim management during leadership transitions

• Budget and organisational restructuring

• Team stabilisation and cultural development

• Mentoring of founders and leadership teams

➽ When things get difficult: trusted hands in a crisis